-
Nippon India Pharma Fund - Growth
Equity healthcare
Overview ( as on 07/05/25 )
NAV
₹492.57
Last change
₹0.12 +0.0%
Fund Size (AUM)
8080.97 Cr
Performance
22.38% (5Y)
Fund Details
Nippon India Pharma Fund - Growth
as of 07/05/25
AUM
8080.97 Cr
Expense Ratio
1.82 %
Benchmark
BSE Healthcare TR INR
ISIN
INF204K01968
Fund Manager
Sailesh Raj Bhan
Exit Load
1.0% if redeemed within 0-1 months
0% if redeemed after 1 months
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Nippon India Pharma Fund - Growth | 13.88% | 21.61% | 22.38% |
| BSE Healthcare TR INR | 19.22% | 20.14% | 22.45% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
13.43% |
Divi's Laboratories Ltd |
9.28% |
Lupin Ltd |
7.27% |
Cipla Ltd |
5.71% |
Apollo Hospitals Enterprise Ltd |
5.31% |
Dr Reddy's Laboratories Ltd |
5.19% |
GlaxoSmithKline Pharmaceuticals Ltd |
3.61% |
Vijaya Diagnostic Centre Ltd |
3.53% |
Abbott India Ltd |
3.46% |
Medplus Health Services Ltd |
3.41% |
Sector Allocation
Healthcare |
100.0% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
24.83% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
24.83% (5Y)
-
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
25.21% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.45% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
22.05% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
22.05% (5Y)
-
